Hummingbird Bioscience

Developer of antibody drugs for cancer treatment

placeSingapore, Singapore, Singapore calendar_todayFounded 2015 groups112 employees language hummingbirdbioscience.com

Registered entities

Innovation

42 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 2,973 times.

YearFilings
20152
20171
20186
20192
20203
20225
20238
202415
202515
202612

Social engagement

Social engagement: 15.4K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

25 investors on record; lead investors include SK, OCTAVE Capital, Novo Holdings, Mirae Asset Venture.

Investor typeCountShare
Venture capital1664%
Private equity416%
Other / undisclosed520%

Recent activity

18 May 2026
Event
ATxSummit panel discussion on AI and innovation
5 Mar 2026
Event
ADC Asia Congress and Biologics Manufacturing Asia
23 Feb 2026
Event
World ADC London
Coming soon